Read + Share
Amedeo Smart
Independent Medical Education
Qin B, Xin L, Liang C, Li L, et al. Efficacy and safety of anti-PD-1 inhibitor versus anti-PD-L1 inhibitor in first-line treatment of extensive-stage small cell lung cancer: a multicenter retrospective study. BMC Cancer 2024;24:100.PMID: 38233798
Email
LinkedIn
Facebook
Twitter
Privacy Policy